 | |
|
In these days where it is
spoken of the relationship between cancer with aspirin,a bond was revealed.
Aspirin reduces death rates from cancer.
Add that to a list the
evidence for the benefits of aspirin in the fight against cancer. 47 according
to a study that analyzes the results of the survey, low-dose ASA be taken to
reduce the risk of disease not only cancer-related death risk reduced by 20%.
However, the wand is connected to the risk of internal bleeding should not be
ignored.
Aspirin medicine for a long
time with cancer of the relationship is on the agenda. Scientific studies
suggest that regular aspirin use at the beginning of the intestine, including
several types of shows that is effective in prevention and treatment.
For example, March 2016
published in the Journal of Oncology by Jama and results of the research on 136
thousand people, twice a week regularly aspirin cancer risk drinkers and 3%
revealed a decrease.
According to the results of
extensive research conducted in the Netherlands in September 2015, aspirin, the
treatment time is about two times the lifespan of cancer patients by boosting
the stomach or intestines.
Research scientists from the
Institute of Francis Crick dated again in London 2015, including aspirin, may
prevent cancer cells hide from the immune system indicating that were.
Aspirin and cancer death risk falls
An article recently
published in scientific journals on the treatment of cancer plus one called
acetyl salicylic acid (ASA) once again showed the benefit of. According to the
study which is the subject of the article, low-dose ASA to be taken and also
reduces the risk of developing cancer and cancer-related death risk by 20%,
reduces the average rate.
The results of the aforementioned
studies ntv.com.tr’evaluating medical oncologist Dr. Canfeza Sezgin, drew
attention to the role of aspirin in the war on cancer, but warned that it could
cause bleeding in some people take aspirin regularly.
"Stopping the spread of cancer cells"
Prof.Sezgin the work of the
assessment of the results is as follows: “for 5 years the researchers of
aspirin breast, prostate and colon cancer patients and examined the effect of
the subject area 47 is made of good quality research. After the completion of
cancer treatment while also examining the effects of aspirin use, the placebo
effect was evaluated. reduction of mortality after cancer aspirin to inhibit
the spread of cancer and ultimately in the direction of the findings were
reached.”
 |
| If you drink aspirin twice a week ...(image 2) |
"There is a need for more detailed studies"
“But this is necessary to
understand whether the usual types are more effective on detailed studies,”
said prof. by the Sezgin, although an old drug, aspirin, continues to maintain
its place among the most important remedies of the last century.
The other studies on the
subject in recent years that are described, referring to said, “very low-dose
ASA to reduce the rates of cancer are known, while the contribution in the
reduction of cancer deaths was not clear. This large study, which was published
last week, uncertainty favor of aspirin by disrupting the medical treatment of
cancer, as well as low-dose ASA use and cancer-related death in both men and
women in the rate of spread of 15% to 20 showed that reduced. Therefore, the researchers
proposes to appropriate patients in addition to ASA treatment. The ratio is
almost equal to the gains obtained by obtained medical treatment,” he said.
Very significant benefit provided cheap drugs
By sezgin Prof. this work is
promising, but further studies to verify these results and other evidence needs
to be obtained regarding the effect of cancer types. Sezgin, provided the
benefit of cheap drugs such as aspirin is important, and could be used to help
in the treatment of various cancers, he say.
Pay attention to the risk of internal bleeding!
Created by pointing out the
risk of internal bleeding the use of aspirin, intuition, research in this
situation were also evaluated, he said, “ultimately, studies of low-dose ASA
use through life-threatening bleeding that was not observed. Oncology patients
with cancer who take aspirin primarily by talking about the potential risks and
benefits with your doctor must make a decision,” he said.
No comments